ArticleJournal of food science2026
Revalorizing Cocoa Endocarp Residues as Novel Ingredients With Potential Prebiotic Effects: A Step Toward Circular Economy.
Article in Journal of food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The interior part of the cocoa husk, known as the cocoa endocarp, is a by-product of the chocolate sector that contains bioactive compounds with health benefits. In this research, the nutritional and physicochemical characteristics, and antioxidant capacity of dehydrated (DC) and lyophilized (LC) cocoa endocarps were evaluated, as well as their prebiotic properties affecting the human intestinal microbiota (IM). A simulated gastrointestinal digestion process was applied to DC and LC prior to 48 h of in vitro fecal fermentation. An increase in the relative abundance (RA) of beneficial intestinal bacteria through fecal fermentation was observed when DC and LC were present, whereas the RA of non-beneficial intestinal bacteria decreased. DC and LC contained nondigestible compounds, including dietary fiber (6.0% and 8.1%, respectively) and phenolic compounds (such as ferulic and fumaric acids, epicatechin, and epigallocatechin gallate), that might contribute to the increase in the RA of beneficial bacteria. DC and LC also promoted modifications in IM metabolic activity via fecal fermentation, reducing the pH (<5.6), producing SCFA, reducing sugar consumption to undetectable levels at 48 h, modifying phenolic compounds, and enhancing antioxidant capacity, as determined by the ferric-reducing antioxidant power (FRAP) method (>70.4 mg Fe/g at 48 h). Despite the different drying processes used, both DC and LC could beneficially alter the metabolic activity and composition of bacterial groups comprising the human IM. These results demonstrate the potential of revalorizing cocoa endocarp as a promising ingredient for developing sustainable formulations with prebiotic properties in the context of the circular economy. PRACTICAL APPLICATIONS: The cocoa endocarp is currently a by-product of the chocolate sector. Drying this material produces an antioxidant ingredient that positively alters human intestinal bacterial populations. The cocoa endocarp could be revalued as a fiber-rich ingredient for developing food products with human health benefits.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.